
Writer
Anand Sathappan
BPharm
Anand Sathappan is a pharmacy graduate with interests in pharmaceutical sciences, pharmacology, and medical writing. He also holds certification in medical coding and has familiarity with pharmacology and healthcare documentation. His work focuses on exploring developments in pharmaceuticals and presenting scientific information in a clear and structured manner.
18
Articles written or reviewed
About Anand
Anand Sathappan (BPharm) is a writer at Pharmacally, with 18 published articles, each checked against primary sources by our editorial team.
On Pharmacally
Articles by Anand Sathappan
Mergers & AcquisitionsShionogi Secures Up to $482 Million BARDA Project BioShield Contract for Fetroja
Health TidingsNuvalent Submits FDA NDA for Neladalkib in Pretreated ALK-Positive NSCLC
New Drug ApprovalSenju Commercializes Avarept 0.3% for Dry Eye Disease in Japan
Health TidingsShionogi Takes Full Control of RADICAVA in $2.5B Deal with Tanabe Pharma
Health TidingsEU Expands Kerendia Label: Bayer’s Finerenone Approved for Broader Heart Failure Population
Health TidingsSanofi’s Sarclisa SC Gets CHMP Nod with OBI Option
Mergers & AcquisitionsNovartis to Acquire Excellergy for Up to $2 Billion, Adds Next-Generation Anti-IgE Antibody Exl-111
New Drug ApprovalNovo Nordisk Wins FDA Approval for Once-Weekly Basal Insulin Awiqli
New Drug ApprovalCorcept’s Relacorilant Combo Approved for Resistant Ovarian CancerOur people
More from our experts
View our team

A. Musharaf Mohammad
Aabha Dey
Aasritha Thippavajjala